ASISA
Seven HLA Group hospitals stand out among the best in spain, according to the Healthcare Reputation Monitor (MRS)
The HLA Group celebrates a significant recognition in the prestigious Healthcare Reputation Monitor (MRS) by Merco.
Dr David Bueno, Doctor in Biology and Director of the UB-EDU1st Chair in Neuroeducation at the University of Barcelona, gave a talk with the title “Cerebroflexia” (“Brainflexia”) as part of the series of Monday sessions.
On 16 June, the last lecture of the academic year took place as part of the Monday sessions, a well-established training initiative at Hospital de Barcelona which, throughout the year, has provided a space for the exchange of knowledge and reflection on health, medicine and healthcare management. This last session was led by Dr David Bueno, Doctor in Biology and Director of the UB-EDU1st Chair of Neuroeducation at the University of Barcelona, who gave a talk with the title ‘Cerebroflexia’ (‘Brainflexia’).
In his presentation, Dr. Bueno offered an innovative perspective on how the human brain adapts and learns throughout life, linking advances in neuroscience with education and health habits.
“Cerebroflexia”, or brain flexibility, was the core idea of his talk, and refers to the brain's flexibility as an essential tool for managing change, improving decision-making and promoting a mentally healthier life, both in personal and professional contexts.
Throughout the academic year, these Monday sessions have served as a meeting point for professionals from the centre, doctors from Assistència Sanitària and other prestigious external experts. As well as highlighting the knowledge of the in-house teams, this activity has enriched the hospital community with complementary perspectives and inspiring experiences.
Some of the most outstanding sessions in recent months included presentations on “Prevention of STDs”, with Dr. Meije and Dr. Llaona, and “Lymphoedema and Alzheimer's” given by Dr. Higueras and Dr. del Río. The sessions on “Technological innovation projects at Hospital de Barcelona” (with Dr. Morillas and Dr. Palau) and “Pharmacogenetics” (with Dr. Padró), to name but a few of the most recent, were also very well received.
Initiatives such as these, with weekly meetings over the last nine months, underline Hospital de Barcelona’s commitment to continuing education and professional excellence, strengthening its position as a leader in the field of co-operative healthcare.